InnoCan Pharma(DE:IP40)
€1.04-0.01 (-0.48%)
DE:IP40
InnoCan Pharma stock forecast
€1.04
At close:-0.01 (-0.48%)
InnoCan Pharma (IP40) Stock Forecast & Price Target
6 Followers
IP40 Analyst Ratings
There are no analyst ratings in the last 3 months.
IP40 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 1.26 | hold | 21.92%Upside | Reiterated | 11/11/26 | ||
| Google Medical - Pharmaceuticals | TipRanks - Google | EUR 1.26 | hold | 21.92%Upside | Reiterated | 11/11/26 | ||
| Anthropic Medical - Pharmaceuticals | TipRanks - Anthropic | EUR 0.95 | hold | -8.56%Downside | Reiterated | 11/11/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 1.26 | hold | 21.92%Upside | Reiterated | 11/11/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 1.26 | hold | 21.92%Upside | Reiterated | 11/11/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 1.26 | hold | 21.92%Upside | Reiterated | 11/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | HoldReiteratedEUR 1.26 | 11/11/26 | 21.92%Upside | ||
| Google Medical - PharmaceuticalsTipRanks - Google | HoldReiteratedEUR 1.26 | 11/11/26 | 21.92%Upside | ||
| Anthropic Medical - PharmaceuticalsTipRanks - Anthropic | HoldReiteratedEUR 0.95 | 11/11/26 | -8.56%Downside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiteratedEUR 1.26 | 11/11/26 | 21.92%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldReiteratedEUR 1.26 | 11/11/26 | 21.92%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldReiteratedEUR 1.26 | 11/11/26 | 21.92%Upside |
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
IP40 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, IP40 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IP40 average Analyst price target in the past 3 months is ―.
IP40 Financial Forecast
ConsensusEUR -0.01
IP40 Earnings Forecast
Next quarter’s earnings estimate for IP40 is -EUR 0.01 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.01. Its overall industry beat the EPS estimate 38.89% of the time in the past 12 months.
ConsensusEUR 4.51M
IP40 Sales Forecast
Next quarter’s sales forecast for IP40 is EUR 4.51M with a range of ― to ―. The previous quarter’s sales results were EUR 4.51M. Its overall industry beat sales estimates 57.45% of the time in the past 12 months.
IP40 Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about InnoCan Pharma?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of InnoCan Pharma?
To buy shares of DE:IP40, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
